Clinical Trials on Nutrient; Excess in Austria
Total 16 results
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess BlastsUnited States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Becton, Dickinson and CompanyCompletedCatheter Related Complication | Vascular Access Site Management | Disinfecting CapBelgium, Austria, Spain, Italy
-
The University of QueenslandAustralasian Kidney Trials NetworkCompletedVascular Access Complication | Hemodialysis Access Failure (Disorder)Netherlands, Switzerland, Canada, France, United Kingdom, Australia, Malaysia
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
-
Menzies School of Health ResearchCharles Darwin University; Northern Territory of Australia as represented by... and other collaboratorsRecruitingAboriginal Health | Cultural Safety | Access to Interpreters | Healthcare Provider TrainingAustralia
-
Singapore General HospitalRecruitingDialysis Access Malfunction | Neointimal HyperplasiaSingapore, Australia
-
IRCCS San RaffaeleCompletedSurgical and the Percutaneous Approach to the Upper Extremity AccessSpain, Sweden, Austria, Belgium, Germany, Switzerland, Italy, United States, France, United Kingdom
-
Biotronik AGCompletedPeripheral Artery Disease | Access Site Complication | Outpatient TreatmentFrance, Austria, Belgium, Switzerland
-
SurModics, Inc.Active, not recruitingHemodialysis Access FailureAustralia, New Zealand
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
University of UlmRecruitingAcute Myeloid Leukemia (AML) | Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)Austria, Germany
-
The University of QueenslandQueensland Children's Hospital; Griffith University; Royal Brisbane and Women... and other collaboratorsRecruitingWound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site ReactionsAustralia, France
-
VenoStentRecruitingChronic Kidney Diseases | Renal Insufficiency | Renal Failure | End Stage Renal Disease | Hemodialysis Access Failure | ESRD | Arteriovenous Fistula | Vascular Access Complication | Catheter Complications | Catheter DysfunctionUnited States
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan